STAT+: The promise of radiopharmaceuticals smacks into safety concerns
Despite excitement over the potential of radiopharmaceuticals as cancer treatments, drug developers are hitting new hurdles.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.